Page 492 - Multidisipliner Covid 19

BÖLÜM 27

J Med. 2020;NEJMoa2006923.
13. Reynolds HR, Adhikari S, Pulgarin C, et al. Renin–angiotensin–aldos-
terone system inhibitors and risk of Covid-19. N Engl J Med. 2020;NEJ
Moa2008975.
14. Bomback AS, Canetta PA, Ahn W, Ahmad SB, Radhakrishnan J, Appel
GB. How COVID-19 has changed the management of glomerular dis-
eases. Clin J Am Soc Nephrol. 2020:CJN.04530420.
15. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme
2 is a functional receptor for the SARS coronavirus. Nature. 2003;426
(6965):450-4.
16. Sommerstein R, Gräni C. Rapid response to preventing a covid-19 pan-
demic: ACE inhibitors as a potential risk factor for fatal Covid-19.
BMJ 2020;368:m810.
17. Jarcho JA, Ingelfinger JR, Hamel MB, D'Agostino RB Sr, Harrington
DP. Inhibitors of the renin-angiotensin-aldosterone system and Covid-
19. N Engl J Med. 2020:NEJMe2012924.
18. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular dis-
ease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020:NEJ
Moa2007621.
19. Danser AHJ, Epstein M, Batlle D. Renin-angiotensin system blockers
and the COVID-19 pandemic: at present there is no evidence to abandon
renin-angiotensin system blockers. Version 2. Hypertension. 2020;75
(6):1382-5.
20. Kuster GM, Pfister O, Burkard T, et al. SARS-CoV2: should inhibitors
of the renin-angiotensin system be withdrawn in patients with COVID-
19? Eur Heart J. 2020;41(19):1801-3.
21. Kuster GM. Renin-angiotensin system and SARS-CoV-2 infection:
there is a before and after. Eur Heart J. 2020;41(22):2128-9.
22. Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-
hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-
38.
23. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and
multi-organ response. Curr Probl Cardiol. 2020:100618.
24. Adapa S, Aeddula NR, Konala VM, et al. COVID-19 and renal failure:
challenges in the delivery of renal replacement therapy. J Clin Med
Res. 2020;12(5):276-85.
25. Anti-2019-nCoV volunteers; Li Z, Wu M, Guo J, et al. Caution on

491